tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX
Holding NBIX?
Track your performance easily

Neurocrine (NBIX) Financial Statements

1,296 Followers

Neurocrine Financial Overview

Neurocrine's market cap is currently ―. The company's EPS TTM is $3.732; its P/E ratio is 31.91; Neurocrine is scheduled to report earnings on February 11, 2025, and the estimated EPS forecast is $1.61. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 622.10M$ 590.20M$ 515.30M$ 515.20M$ 498.80M
Gross Profit$ 614.10M$ 581.00M$ 507.80M$ 506.70M$ 487.60M
EBIT$ 190.30M$ 98.60M$ 35.60M$ 199.30M$ 115.60M
EBITDA$ 196.80M$ 113.00M$ 41.80M$ 205.00M$ 121.10M
Net Income Common Stockholders$ 129.80M$ 65.00M$ 43.40M$ 147.70M$ 83.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.23B$ 1.04B$ 1.21B$ 1.03B$ 1.10B
Total Assets$ 3.54B$ 3.31B$ 3.47B$ 3.25B$ 2.85B
Total Debt$ 251.40M$ 256.20M$ 375.70M$ 428.40M$ 255.80M
Net Debt$ -976.60M$ -782.70M$ -834.90M$ -603.20M$ -839.30M
Total Liabilities$ 816.10M$ 795.80M$ 1.09B$ 1.02B$ 846.10M
Stockholders Equity$ 2.72B$ 2.51B$ 2.39B$ 2.23B$ 2.00B
Cash Flow-
Free Cash Flow$ 149.90M$ 53.00M$ 119.10M$ 118.10M$ 204.40M
Operating Cash Flow$ 158.00M$ 64.60M$ 130.30M$ 123.50M$ 212.00M
Investing Cash Flow$ 24.70M$ -28.20M$ -55.00M$ -201.80M$ -97.30M
Financing Cash Flow$ 26.40M$ -293.00M$ 69.90M$ 35.40M$ 18.80M
Currency in USD

Neurocrine Earnings and Revenue History

Neurocrine Debt to Assets

Neurocrine Cash Flow

Neurocrine Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis